Cargando…
Secretoneurin Gene Therapy Improves Blood Flow in an Ischemia Model in Type 1 Diabetic Mice by Enhancing Therapeutic Neovascularization
Deficient angiogenesis after ischemia may contribute to worse outcome of peripheral arterial disease in patients with diabetes mellitus. Based on our previous work where we demonstrated that Secretoneurin (SN) is up-regulated under hypoxic conditions and enhances angiogenesis, we analyzed the therap...
Autores principales: | Schgoer, Wilfried, Theurl, Markus, Albrecht-Schgoer, Karin, Jonach, Verena, Koller, Bernhard, Lener, Daniela, Franz, Wolfgang M., Kirchmair, Rudolf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781158/ https://www.ncbi.nlm.nih.gov/pubmed/24086307 http://dx.doi.org/10.1371/journal.pone.0074029 |
Ejemplares similares
-
The novel angiogenic cytokine secretoneurin promotes angiogenesis, arteriogenesis and vasculogenesis in the mouse hind-limb ischemia model
por: Schgoer, Wilfried, et al.
Publicado: (2008) -
Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site
por: Hadzijusufovic, Emir, et al.
Publicado: (2017) -
Conditional knockout of the secretogranin II gene to reveal biological functions of secretoneurin
por: Leierer, Johannes, et al.
Publicado: (2008) -
Cerebral Malaria: Current Clinical and Immunological Aspects
por: Albrecht-Schgoer, Karin, et al.
Publicado: (2022) -
Low Energy Shock Wave Therapy Induces Angiogenesis in Acute Hind-Limb Ischemia via VEGF Receptor 2 Phosphorylation
por: Holfeld, Johannes, et al.
Publicado: (2014)